Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Amikacin

A semisynthetic aminoglycoside antibiotic made from kanamycin A, first described in 1972: it is given intravenously or intramuscularly for serious Gram-negative infections, including those resistant to other aminoglycosides. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Its side chain mirrors that of butirosin, an antibiotic made by the bacterium Bacillus circulans: it shields the molecule from many of the enzymes bacteria use to inactivate other aminoglycosides.

AmikacinGo to the active ingredient →
AmikacinActive ingredientAmikacinCat. No. P-A118-001CAS 37517-28-5

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Reference substanceAmikacin CRSEDQM code A0368000Family Amikacin

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.